SLRN
ACELYRIN, INC.
6.88
USD
This page is just a preview of the data found in TrendSpider’s full version
ACELYRIN, INC. stock is down -24.64% since 30 days ago. The next earnings date is Feb 8, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 100% of the previous 1 December’s closed higher than November. In the last 5 Unusual Options Trades, there were 2 CALLs, 3 PUTs. 100% of analysts rate it a buy.
| Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
|---|---|---|---|---|---|
| 12 Oct 18:58 | 19 Jan, 2024 | 10.00 | 833 | ||
| 20 Oct 15:59 | 20 Oct, 2023 | 25.00 | 530 | ||
| 20 Oct 16:00 | 20 Oct, 2023 | 25.00 | 530 | ||
| 20 Oct 16:00 | 20 Oct, 2023 | 25.00 | 530 | ||
| 26 Oct 14:08 | 19 Jan, 2024 | 10.00 | 1469 |
ACELYRIN is a late-stage clinical biopharma company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines. Our principal executive offices are located at 4149 Liberty Canyon Road, Agoura Hills, California.
